The story said, "Israel’s Midaat Association responded to the report on the deaths, explaining that when vaccines are administered to at-risk populations “there may be unfortunate cases. One should not infer from this about the safety of the vaccine, but welcome the transparency required from the pharma companies in the drug approval process

.'"The association noted that in large trials of tens of thousands of people, death can occur without any connection to the trial, but that companies such as Pfizer are required to report those deaths."